跳至主要内容
临床试验/ACTRN12624000407594
ACTRN12624000407594尚未招募Unknown

Investigating the effectiveness of mindfulness meditation and clinical hypnosis for injury-related pain management in competitive athletes: A replicated single-case experimental design

The University of Queensland0 个研究点目标入组 18 人开始时间: 2024年4月3日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • a) be a competitive athlete (i.e., compete at a level beyond recreational or casual participation. This includes athletes who participate in regional, national, or international competitions, and those who are members of competitive teams or clubs),
  • b) currently have a sport or exercise-related injury that resulted in an average pain
  • intensity greater than or equal to 3 on a 0-10 numerical rating scale in the past
  • week, and for which the predicted recovery time at the point of study enrolment is
  • greater than 5 weeks
  • c) be 18 years of age or over,
  • d) read, speak, and understand the English language,
  • e) have access to the internet on a computer or smartphone,
  • f) have access to a set of earphones,
  • g) be willing to be randomly assigned to both conditions and listen to five 20-minute treatment sessions (one per day),
  • h) be willing to participate in a brief daily survey for 25 consecutive days.

排除标准

  • a) Current alcohol or substance dependence;
  • b) Pain condition for which surgery has been recommended and is planned;
  • c) Current or past participation in a research study with treatment components that may overlap those in the current study;
  • d) Current or history of diagnosis of primary psychotic or major thought disorder within the past 5 years;
  • e) Psychiatric hospitalization within the past 6 months;
  • f) Psychiatric or behavioural conditions in which symptoms were unstable or severe within the past 6 months;
  • g) Active malignancy (e.g., cancer not in remission), terminal illnesses, or serious medical conditions that may interfere with either study participation or with receiving potential treatment benefits (e.g., severe lupus).

研究者

相似试验